BioRestorative Therapies, Inc.
Market Cap
$2.24M
P/E Ratio
-0.17
EPS
$-1.46
Dividend Yield
0.00%
52-Week Range
$0.19 — $2.10
Volume
1.47M
Avg Volume
9.07M
Beta
0.41
P/E (TTM)
-0.17
Forward P/E
—
PEG Ratio
0.01
P/S (TTM)
7.01
P/B (TTM)
1.25
P/FCF
—
EV/EBITDA
—
EV/Sales
—
ROE (TTM)
-2.33%
ROA (TTM)
-2.25%
ROIC
—
Gross Margin
0.80%
Operating Margin
-37.85%
Net Margin
—
Debt/Equity
0.00
Current Ratio
1.37
EPS Growth (YoY)
—
Revenue Growth (YoY)
—
EPS Growth (3Y)
+0.59%
EPS Growth (5Y)
+0.49%
Sales Growth (3Y)
+1.19%
Sales Growth (5Y)
+0.55%
EPS Est (This Year)
$-1.05
EPS Est (Next Year)
$-0.91
Dividend Yield
—
Annual Dividend
—
Payout Ratio
—
Frequency
—
Ex-Dividend Date
—
Cash/Share
$0.49
Institutional %
—
Inst. Net Change
—
Insider Net Shares (90d)
—
Outstanding Shares
8.88M
Float
5.99M
Free Float %
67.53%
Sector
Healthcare
Industry
Biotechnology
Country
US
Exchange
NASDAQ
IPO Date
2012-12-05
Employees
11
CEO
Lance Alstodt
Index Membership
—
Website
https://www.biorestorative.com
BioRestorative Therapies, Inc. (BRTX) is a healthcare company in the biotechnology industry listed on the NASDAQ. With a market capitalization of $2.24M, a P/E ratio of -0.17, BRTX is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare BRTX against other stocks using dozens of fundamental and technical filters.
BioRestorative Therapies, Inc. (BRTX) has a trailing twelve-month (TTM) P/E ratio of -0.17. This is below the market average, which may suggest the stock is undervalued or has lower growth expectations. The P/E ratio measures how much investors are willing to pay per dollar of earnings.
No, BioRestorative Therapies, Inc. (BRTX) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.
BioRestorative Therapies, Inc. (BRTX) has a market capitalization of $2.24 million, classifying it as a micro-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.